Preview record
TB-500 5 mg
Research reagent · 5 mg
A research material sold on the market under the TB-500 label, lyophilised format, 5 mg per vial (declared).
The price is provisional. Ordering is not open yet — contact us and we will let you know when sales start.
Tell me when sales open01 / About the material
Description
"TB-500" is a market label associated with thymosin β4 — a natural 43-amino-acid actin-binding peptide. No single standard ties the name to one molecule, so we state this material's identity — full-length peptide or fragment — only from the analytical documentation of a specific batch.
The material is intended for laboratory research.
Research context
The thymosin β4 literature covers cytoskeletal regulation, cell migration, and tissue-repair models; clinical studies in specific indications did not lead to registration. How "TB-500" differs from thymosin β4 is covered in our comparison article.
- TB-500 vs thymosin β4: what is the difference?
- Why are BPC-157 and TB-500 always mentioned together?
For laboratory and research purposes. Not intended for human use.
03 / FAQ
Frequent questions
- What is this material intended for?
- Strictly for laboratory research purposes. The material is not intended for human use and is not a medicine.
- Where is the batch documentation?
- Analytical documents appear on the page once their link to a specific batch is verified. Until then the documentation status honestly reads "pending review".
- When will ordering open?
- Ordering opens once catalogue verification, payment, and delivery are activated. Contact us and we will let you know when sales start.
04 / Catalogue
